Chapter
Immunization Strategies Against Pulmonary Tuberculosis: Considerations of T Cell Geography
Abstract
Pulmonary tuberculosis (TB) remains a global health concern with an astounding 9 million new cases and 2 million deaths per year. This leading infectious cause of death remains highly prevalent with one third of the world’s population latently infected with Mycobacteriumtuberculosis(M.tb) despite routine vaccination against TB in endemic areas. The only approved TB vaccine is the Bacille Calmette-Guerin (BCG), which provides protection against …
Authors
Horvath CN; Xing Z
Book title
The New Paradigm of Immunity to Tuberculosis
Series
Advances in Experimental Medicine and Biology
Volume
783
Pagination
pp. 267-278
Publisher
Springer Nature
Publication Date
2013
DOI
10.1007/978-1-4614-6111-1_14
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
Adenoviruses, HumanAdministration, IntranasalAnimalsChemotaxis, LeukocyteGenetic VectorsGlobal HealthHumansImmunity, MucosalImmunization, SecondaryInjections, IntramuscularLungMiceMycobacterium tuberculosisOrgan SpecificityPrevalenceRespiratory SystemT-Lymphocyte SubsetsTuberculosis VaccinesTuberculosis, PulmonaryVaccinationVaccines, SubunitVaccines, Synthetic